Cargando…

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

Limited substrates content is a major hurdle dampening the antitumor effect of catalytic therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with ·OH generation under ultrasound irradiation is fabricated and utilized for catalytic cancer therapy. This interplanar heteroju...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yong, Mao, Zhuo, Wang, Ying, Pan, Chao, Ou, Meitong, Zhang, Hanjie, Zeng, Weiwei, Ji, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065124/
https://www.ncbi.nlm.nih.gov/pubmed/35504879
http://dx.doi.org/10.1038/s41467-022-30166-1
_version_ 1784699516347219968
author Kang, Yong
Mao, Zhuo
Wang, Ying
Pan, Chao
Ou, Meitong
Zhang, Hanjie
Zeng, Weiwei
Ji, Xiaoyuan
author_facet Kang, Yong
Mao, Zhuo
Wang, Ying
Pan, Chao
Ou, Meitong
Zhang, Hanjie
Zeng, Weiwei
Ji, Xiaoyuan
author_sort Kang, Yong
collection PubMed
description Limited substrates content is a major hurdle dampening the antitumor effect of catalytic therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with ·OH generation under ultrasound irradiation is fabricated and utilized for catalytic cancer therapy. This interplanar heterojunction is prepared through replacing chlorine from iron oxychloride with hydroxyl. Benefiting from the longer hydroxyl bond length and enhanced affinity with water, the alkali replacement treatment integrates interplanar heterojunction synthesis and exfoliation in one step. In particular, a build-in electric field facilitated Z-scheme interplanar heterojunction is formed due to the aligning Fermi levels. The holes on the valence band of FeOCl have great ability to catalyze O(2) evolution from H(2)O, meanwhile, the generated O(2) is immediately and directly reduced to H(2)O(2) by the electrons on the conductive band of FeOOH. The self-supplying H(2)O(2) ability guarantees efficient ·OH generation via the Fenton-like reaction catalyzed by FeOCl/FeOOH NSs, which exhibits excellent anti-tumor performance.
format Online
Article
Text
id pubmed-9065124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90651242022-05-04 Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy Kang, Yong Mao, Zhuo Wang, Ying Pan, Chao Ou, Meitong Zhang, Hanjie Zeng, Weiwei Ji, Xiaoyuan Nat Commun Article Limited substrates content is a major hurdle dampening the antitumor effect of catalytic therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with ·OH generation under ultrasound irradiation is fabricated and utilized for catalytic cancer therapy. This interplanar heterojunction is prepared through replacing chlorine from iron oxychloride with hydroxyl. Benefiting from the longer hydroxyl bond length and enhanced affinity with water, the alkali replacement treatment integrates interplanar heterojunction synthesis and exfoliation in one step. In particular, a build-in electric field facilitated Z-scheme interplanar heterojunction is formed due to the aligning Fermi levels. The holes on the valence band of FeOCl have great ability to catalyze O(2) evolution from H(2)O, meanwhile, the generated O(2) is immediately and directly reduced to H(2)O(2) by the electrons on the conductive band of FeOOH. The self-supplying H(2)O(2) ability guarantees efficient ·OH generation via the Fenton-like reaction catalyzed by FeOCl/FeOOH NSs, which exhibits excellent anti-tumor performance. Nature Publishing Group UK 2022-05-03 /pmc/articles/PMC9065124/ /pubmed/35504879 http://dx.doi.org/10.1038/s41467-022-30166-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kang, Yong
Mao, Zhuo
Wang, Ying
Pan, Chao
Ou, Meitong
Zhang, Hanjie
Zeng, Weiwei
Ji, Xiaoyuan
Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title_full Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title_fullStr Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title_full_unstemmed Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title_short Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
title_sort design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065124/
https://www.ncbi.nlm.nih.gov/pubmed/35504879
http://dx.doi.org/10.1038/s41467-022-30166-1
work_keys_str_mv AT kangyong designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT maozhuo designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT wangying designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT panchao designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT oumeitong designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT zhanghanjie designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT zengweiwei designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy
AT jixiaoyuan designofatwodimensionalinterplanarheterojunctionforcatalyticcancertherapy